治疗和预防化疗所致中性粒细胞减少症的生物仿制药 Filgrastim (Nivestim®)：NEXT观察性研究的结果

{"title":"治疗和预防化疗所致中性粒细胞减少症的生物仿制药 Filgrastim (Nivestim®)：NEXT观察性研究的结果","authors":"","doi":"10.29011/2577-1418.000133","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":176602,"journal":{"name":"Hematological Diseases and Therapies","volume":"35 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biosimilar Filgrastim (Nivestim®) in the Treatment and Prevention of Chemotherapy-Induced Neutropenia: Results of the NEXT Observational Study\",\"authors\":\"\",\"doi\":\"10.29011/2577-1418.000133\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":176602,\"journal\":{\"name\":\"Hematological Diseases and Therapies\",\"volume\":\"35 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematological Diseases and Therapies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29011/2577-1418.000133\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematological Diseases and Therapies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2577-1418.000133","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}